The first step in the development of the allergic conjunctivitis is the penetration of the allergen through the epithelial layer.
The acquisition aligns with Grünenthal’s strategy to expand its product portfolio. Credit: fizkes / Shutterstock. Grünenthal has announced the acquisition of US-based Valinor Pharma, along
AstraZeneca is developing a novel type of mRNA vaccine that can be administered as a shelf-stable skin patch instead of a shot, potentially making distribution